sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Asia-Pacific POCT Device Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Asia-Pacific POCT Device Market Analysis, Companies Profiles, Size, Share, Growth,...

Home / Categories / Healthcare
Asia-Pacific POCT Device Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
Asia-Pacific POCT Device Market Analysis,...
Report Code
RO1/110/1352

Publish Date
01/Mar/2017

Pages
230
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The Asia-Pacific POCT Device Market is accounted to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, it is growing at a CAGR of 9.2% in the forecast period 2017 to 2024

The major factors driving the market for Global Point-Of-Care Testing Market, such as increasing geriatric population, increase in infectious diseases (hepatitis, HIV infection, influenza, respiratory infections and others), technological advancements, introduction of home-based point of care devices, and rapid economic development in the emerging economies.

The key market players for Asia-Pacific Point of Care Testing Market are listed below;

Abbott,
Alere Inc.,
Siemens AG
Becton,
Dickinson and Company,
Johnson & Johnson Services Inc.,
PTS Diagnostics,
Instrumentation Laboratory,
Nova Biomedical,
Beckman Coulter, Inc.,
Werfenlife

The market is further segmented into;
Prescription Mode
Distribution Channel
End User
Geography
The Asia-Pacific POCT Device Market is segmented on the basis of product type, prescription mode, distribution channel, end user, and geography.
On the basis of prescription mode, the Asia-Pacific point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.
The OTC testing is projected to witness higher growth rate of 9.7% during the forecast period to reach a value of USD 1.68 billion by 2024.
On the basis of distribution channel, the Asia-Pacific point-of-care testing market is segmented into direct tenders and retail.
In 2017, the direct tender market is expected to dominate the market with a value of USD 1.67 billion.
On the basis of end users, the Asia-Pacific point-of-care testing market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.

Based on geography, the Asia-Pacific Point of Care Testing market is segmented into 11 geographical regions, such as,
China,
Japan,
India,
South Korea,
Australia,
Thailand,
Malaysia,
Singapore,
Indonesia,
Philippines


Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific Point of Care Testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.




OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com